A post-hoc systems serology analysis within a controlled human infection trial evaluating reticulocyte-binding protein homolog 5 (RH5) showed that the magnitude of anti-RH5 IgA in plasma is associated with a delayed time to malaria diagnosis (50). The gene discussed is CD79A; the disease is malaria.